Xeris Biopharma share price today

(XERS)

Xeris Biopharma share price is $3.49 & ₹296.57 as on 21 Dec 2024, 2.30 'hrs' IST

$3.49

▲

0.08

(2.35%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Xeris Biopharma share price in Dollar and Rupees. Guide to invest in Xeris Biopharma from India. Also see the sentimental analysis on Indian investors investing in Xeris Biopharma. Get details on the Indian mutual funds that are investing in Xeris Biopharma. Get Analyst recommendations and forecasts along with all the Xeris Biopharma's financials.

Xeris Biopharma share price movements

Today's Low: $3.40
Today's High: $3.57
$3.49
2.58%
Downside
Day's Volatility :4.63%
Upside
2.1%
52 Weeks Low: $1.69
52 Weeks High: $3.87
$3.49
51.58%
Downside
52 Weeks Volatility :56.33%
Upside
9.82%

Xeris Biopharma Returns

Period	Xeris Biopharma Holdings Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	23.55%	-12.2%	0.0%
6 Months	61.61%	-6.9%	0.0%
1 Year	63.16%	2.7%	0.0%
3 Years	87.36%	-0.2%	-17.3%

Xeris Biopharma Key Statistics

in dollars & INR

Previous Close	$3.41
Open	$3.35
Today's High	$3.565
Today's Low	$3.4
Market Capitalization	$484.5M
Today's Volume	$1.5M
52 Week High	$3.87
52 Week Low	$1.69
Revenue TTM	$187.4M
EBITDA	$-33.1M
Earnings Per Share (EPS)	$-0.43
Profit Margin	-33.69%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-617.16%

How to invest in Xeris Biopharma from India?

It is very easy for Indian residents to invest directly in Xeris Biopharma from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Xeris Biopharma stock in both Indian Rupees (INR) and US Dollars (USD). Search for Xeris Biopharma or XERS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Xeris Biopharma or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Xeris Biopharma shares which would translate to 0.243 fractional shares of Xeris Biopharma as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Xeris Biopharma, in just a few clicks!

Returns in Xeris Biopharma for Indian investors in Rupees

Investment Value

₹1,00,000

Xeris Biopharma investment value today

Current value as on today

₹1,69,081

Returns

₹69,081

(+69.08%)

Returns from Xeris Biopharma Stock

₹66,986 (+66.99%)

Dollar Returns

₹2,095 (+2.1%)

Indian investors sentiment towards Xeris Biopharma

79%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Xeris Biopharma on INDmoney from India has grown in the last 30 days as on Dec 21, 2024. 79% more investors are searching Xeris Biopharma in the last 30 days versus the previous period.

Global Institutional Holdings in Xeris Biopharma

BlackRock Inc
6.93%
Vanguard Group Inc
5.21%
Caxton Corp
3.43%
CenterBook Partners LP
2.34%
Geode Capital Management, LLC
2.24%
State Street Corp
2.15%

Analyst Recommendation on Xeris Biopharma

Buy

91%Buy

8%Hold

0%Sell

Based on 12 Wall street analysts offering stock ratings for Xeris Biopharma(by analysts ranked 0 to 5 stars)

Based on 12 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Xeris Biopharma

What analysts predicted

Upside of 36.58%

Current:

$3.49

Target:

$4.77

Insights on Xeris Biopharma

Price Movement
In the last 7 days, XERS stock has moved up by 4.0%
Increasing Revenue
Revenue is up for the last 3 quarters, 40.63M → 54.26M (in $), with an average increase of 13.4% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -15.00M → -15.73M (in $), with an average decrease of 4.9% per quarter

Xeris Biopharma Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$2.5M	↑ 58.42%
Net Income	$-60.1M	↑ 126.26%
Net Profit Margin	-2.4K%	↓ 730.76%

	FY19	Y/Y Change
Revenue	$2.7M	↑ 10.43%
Net Income	$-125.6M	↑ 109.02%
Net Profit Margin	-4.6K%	↓ 2176.2%

	FY20	Y/Y Change
Revenue	$20.2M	↑ 640.45%
Net Income	$-91.1M	↓ 27.42%
Net Profit Margin	-452.2%	↑ 4161.32%

	FY21	Y/Y Change
Revenue	$110.2M	↑ 447.0%
Net Income	$-94.7M	↑ 3.86%
Net Profit Margin	-85.86%	↑ 366.34%

	FY22	Y/Y Change
Revenue	$110.2M	↑ 0.0%
Net Income	$-94.7M	↑ 0.0%
Net Profit Margin	-85.86%	↑ 0.0%

	FY23	Y/Y Change
Revenue	$163.9M	↑ 48.68%
Net Income	$-62.3M	↓ 34.23%
Net Profit Margin	-37.98%	↑ 47.88%

	Q2 FY23	Q/Q Change
Revenue	$38.0M	↑ 14.5%
Net Income	$-19.8M	↑ 17.87%
Net Profit Margin	-52.2%	↓ 1.49%

	Q3 FY23	Q/Q Change
Revenue	$48.3M	↑ 27.13%
Net Income	$-12.2M	↓ 38.57%
Net Profit Margin	-25.23%	↑ 26.97%

	Q4 FY23	Q/Q Change
Revenue	$44.4M	↓ 8.13%
Net Income	$-13.4M	↑ 9.85%
Net Profit Margin	-30.16%	↓ 4.93%

	Q1 FY24	Q/Q Change
Revenue	$40.6M	↓ 8.45%
Net Income	$-19.0M	↑ 41.75%
Net Profit Margin	-46.71%	↓ 16.55%

	Q2 FY24	Q/Q Change
Revenue	$48.1M	↑ 18.28%
Net Income	$-15.0M	↓ 20.94%
Net Profit Margin	-31.22%	↑ 15.49%

	Q3 FY24	Q/Q Change
Revenue	$54.3M	↑ 12.91%
Net Income	$-15.7M	↑ 4.89%
Net Profit Margin	-29.0%	↑ 2.22%

	FY18	Y/Y Change
Profit	$2.4M	↑ 56.12%

	FY19	Y/Y Change
Profit	$1.1M	↓ 53.82%

	FY20	Y/Y Change
Profit	$10.8M	↑ 867.56%

	FY21	Y/Y Change
Profit	$87.6M	↑ 709.22%

	FY22	Y/Y Change
Profit	$87.6M	↑ 0.0%

	FY23	Y/Y Change
Profit	$135.3M	↑ 54.39%

	Q2 FY23	Q/Q Change
Profit	$30.5M	↑ 9.24%

	Q3 FY23	Q/Q Change
Profit	$40.1M	↑ 31.74%

	Q4 FY23	Q/Q Change
Profit	$34.1M	↓ 14.98%

	Q1 FY24	Q/Q Change
Profit	$32.0M	↓ 6.31%

	Q2 FY24	Q/Q Change
Profit	$37.6M	↑ 17.55%

	Q3 FY24	Q/Q Change
Profit	$40.7M	↑ 8.28%

	FY18	Y/Y Change
Operating Cash Flow	$-56.3M	↑ 128.19%
Investing Cash Flow	$-68.3M	↑ 9651.57%
Financing Cash Flow	$128.2M	↑ 264.87%

	FY19	Y/Y Change
Operating Cash Flow	$-104.3M	↑ 85.41%
Investing Cash Flow	$-2.4M	↓ 96.51%
Financing Cash Flow	$80.5M	↓ 37.19%

	FY20	Y/Y Change
Operating Cash Flow	$-80.6M	↓ 22.8%
Investing Cash Flow	$-27.4M	↑ 1050.02%
Financing Cash Flow	$126.1M	↑ 56.54%

	FY21	Y/Y Change
Operating Cash Flow	$-95.5M	↑ 18.59%
Investing Cash Flow	$98.0M	↓ 457.47%
Financing Cash Flow	$27.2M	↓ 78.39%

	FY22	Y/Y Change
Operating Cash Flow	$-102.9M	↑ 7.7%
Investing Cash Flow	$34.5M	↓ 64.82%
Financing Cash Flow	$127.5M	↑ 367.84%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-13.7M	↓ 47.42%
Investing Cash Flow	$8.5M	↑ 0.0%
Financing Cash Flow	$556.0K	↓ 164.43%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$-14.6M	↑ 6.3%
Investing Cash Flow	$14.7M	↑ 73.39%
Financing Cash Flow	$-72.0K	↓ 112.95%

Xeris Biopharma Technicals Summary

Sell

Neutral

Buy

Xeris Biopharma is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Xeris Biopharma Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Xeris Biopharma Holdings Inc	11.44%	61.61%	63.16%	87.36%	87.36%
Regeneron Pharmaceuticals, Inc.	-4.72%	-33.43%	-16.35%	14.7%	89.27%
Biontech Se	9.01%	28.55%	5.71%	-57.13%	220.59%
Alnylam Pharmaceuticals, Inc.	-3.99%	7.16%	25.05%	27.48%	103.59%
Vertex Pharmaceuticals Incorporated	-12.1%	-16.49%	-2.12%	78.05%	80.31%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Xeris Biopharma Holdings Inc	NA	NA	NA	-0.26	-6.17	-0.09	NA	-0.19
Regeneron Pharmaceuticals, Inc.	17.67	17.67	1.06	45.05	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.17	0.54	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Xeris Biopharma Holdings Inc	Buy	$484.5M	87.36%	NA	-33.69%
Regeneron Pharmaceuticals, Inc.	Buy	$78.5B	89.27%	17.67	33.61%
Biontech Se	Buy	$26.8B	220.59%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$30.7B	103.59%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$115.2B	80.31%	32.84	-4.51%

About Xeris Biopharma

xeris aspires to break through this restraint by developing ultra-low volume, ready-to-use biotherapeutics delivered through patient-friendly injectable devices. products built on our xeriject technologies could potentially ease the pain of injections for hundreds of millions of patients.

Organization	Xeris Biopharma
Employees	377
CEO	Mr. John P. Shannon
Industry	Health Technology

Management People of Xeris Biopharma

Name	Title
Mr. John P. Shannon	CEO & Director
Mr. Steven M. Pieper	Chief Financial Officer
Ms. Beth P. Hecht J.D.	Chief Legal Officer & Corporate Secretary
Mr. Paul R. Edick J.D.	Senior Advisor
Dr. Kenneth E. Johnson Pharm. D., Pharm.D.	Senior VP of Global Development & Medical Affairs
Ms. Allison Wey	Senior Vice President of Investor Relations & Corporate Communications
Mr. Brian Conner	SVP of Quality and Chief Compliance & Risk Officer
Ms. Kendal Korte	Senior Vice President of Human Resources
Mr. Kevin McCulloch	Chief Commercial Officer

Important FAQs about investing in Xeris Biopharma from India :

What is Xeris Biopharma share price today?

Xeris Biopharma share price today stands at $3.49, Open: $3.35 ; Previous Close: $3.41 ; High: $3.57 ; Low: $3.40 ; 52 Week High: $3.87 ; 52 Week Low: $1.69. The stock opens at $3.35, after a previous close of $3.41. The stock reached a daily high of $3.57 and a low of $3.40, with a 52-week high of $3.87 and a 52-week low of $1.69.

Can Indians buy Xeris Biopharma shares?

Yes, Indians can invest in the Xeris Biopharma (XERS) from India.

With INDmoney, you can buy Xeris Biopharma at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Xeris Biopharma at zero transaction cost.

How can I buy Xeris Biopharma shares from India?

It is very easy to buy Xeris Biopharma from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Xeris Biopharma be purchased?

Yes, you can buy fractional shares of Xeris Biopharma with INDmoney app.

What are the documents required to start investing in Xeris Biopharma stocks?

To start investing in Xeris Biopharma, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.